Bank of New York Mellon Corp - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 34 filers reported holding NRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,634
-46.2%
10,1290.0%0.00%
Q2 2023$4,897
-26.6%
10,1290.0%0.00%
Q1 2023$6,676
-40.6%
10,1290.0%0.00%
Q4 2022$11,243
+60.6%
10,1290.0%0.00%
Q3 2022$7,000
+16.7%
10,1290.0%0.00%
Q2 2022$6,000
-76.0%
10,1290.0%0.00%
Q1 2022$25,00010,1290.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders